Last update 20 Mar 2025

Human Chorionic Gonadotrophin (Fuji Pharma)

Overview

Basic Info

Drug Type
Hormone
Synonyms-
Target
LHCGR
Action
agonists
Mechanism
LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists)
Therapeutic Areas
Congenital DisordersEndocrinology and Metabolic DiseaseUrogenital Diseases+ [1]
Active Indication
Abortion, HabitualAbortion, ThreatenedCryptorchidism+ [2]
Inactive Indication-
Originator Organization
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
Active Organization
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (29 Aug 2001),
Abortion, HabitualAbortion, ThreatenedCryptorchidism+ [2]
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Human Chorionic Gonadotrophin (Fuji Pharma)
ChiCTR1800016285
/ SuspendedNot ApplicableIIT
Effects of double trigger by gonadotrophin-releasing hormone agonist and human chorionic gonadotrophin on advance-aged females receiving in vitro fertilization treatment
100 Clinical Results associated with Human Chorionic Gonadotrophin (Fuji Pharma)
Login to view more data
100 Translational Medicine associated with Human Chorionic Gonadotrophin (Fuji Pharma)
Login to view more data
100 Patents (Medical) associated with Human Chorionic Gonadotrophin (Fuji Pharma)
Login to view more data
100 Deals associated with Human Chorionic Gonadotrophin (Fuji Pharma)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Abortion, Habitual
Japan
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
29 Aug 2001
Abortion, Threatened
Japan
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
29 Aug 2001
Cryptorchidism
Japan
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
29 Aug 2001
Infertility
Japan
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
29 Aug 2001
Infertility, Male
Japan
Fuji Pharma Co., Ltd.Fuji Pharma Co., Ltd.
29 Aug 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free